HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
India Health Wellness

Bayer Leads Push For Self-Care In India As Local Business Launches

  • News

Executive Summary

Bayer has launched a dedicated Consumer Health business in India to market products in key OTC categories. The company is also working to bring different stakeholders together through the creation of a new organization dedicated to promoting self-care in the South Asian country.

You may also be interested in...



Haleon Establishing Own Distribution In India To Unleash Growth

Haleon is taking back full control of its interests in India by terminating a distribution deal for its OTC and oral care brands signed with Hindustan Unilever in 2020.

Bayer Sees Increased Demand Across All Consumer Health Categories In Q1

Bayer Consumer Health reported sales up in all categories and regions in the first quarter of 2022, with demand particularly high for dietary supplements and cough & cold products.

Successful Innovation And Supplement Gains Drive 'Exceptional' Q3 For Bayer

Successful launches and increased demand for dietary supplements helped to drive up Bayer's Consumer Health's sales double-digits in Q3. As a consequence, the German firm has raised its 2021 sales guidance for Consumer Health for the second time so far this year.

Table

View full table

Related Content

HBW Insight
HBW Insight
HBW Insight

Topics

Tags:
India Health Wellness
Latest Headlines

MacuHealth Asserts ‘Rigorous Process’ In Research Supporting Claims, But No Bill Of Health From NAD

Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement

FDA’s Linda Katz Takes MoCRA Questions At IBA Regulatory Workshop

Health And Wellness Weekly Trademarks Review: 19 September

See All
UsernamePublicRestriction

Register

RS151428

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By